Fresenius Medical Disappoints With Weak US Dialysis Volumes

Fresenius Medical Care AG posted first-quarter results that disappointed investors as weak US dialysis volumes continued to weigh on the German company. The shares slumped.

First-quarter net income rose to €251 million ($293 million) on an adjusted basis, the company said Tuesday, below the average analyst estimate of €256 million.